GoodRx Holdings, Inc.
GDRX
$3.31
-$0.06-1.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.23% | 2.57% | 0.99% | 8.50% | 5.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23% | 2.57% | 0.99% | 8.50% | 5.76% |
| Cost of Revenue | 12.47% | 7.19% | 14.27% | -37.59% | -27.35% |
| Gross Profit | 0.52% | 2.26% | 0.22% | 13.85% | 8.89% |
| SG&A Expenses | -6.44% | -7.04% | -9.91% | -9.02% | 12.44% |
| Depreciation & Amortization | 16.29% | 31.18% | 717.59% | -46.90% | 5.39% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.47% | -1.31% | 16.06% | -19.90% | 5.46% |
| Operating Income | 34.87% | 36.35% | -34.40% | 153.24% | 8.58% |
| Income Before Tax | 68.10% | 5,588.74% | 146.31% | 117.41% | -3.50% |
| Income Tax Expenses | 35.99% | 331.34% | 278.36% | 151.16% | 110.60% |
| Earnings from Continuing Operations | 91.86% | 1,195.34% | 126.05% | 110.30% | -88.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.86% | 1,195.34% | 126.05% | 110.30% | -88.61% |
| EBIT | 34.87% | 36.35% | -34.40% | 153.24% | 8.58% |
| EBITDA | 26.31% | 34.08% | -33.55% | 815.08% | 7.09% |
| EPS Basic | 102.25% | 1,219.23% | 127.57% | 111.17% | -87.52% |
| Normalized Basic EPS | 77.72% | 62.91% | -35.96% | 125.04% | 5.46% |
| EPS Diluted | 102.25% | 1,219.23% | 127.57% | 110.74% | -87.29% |
| Normalized Diluted EPS | 81.48% | 62.91% | -36.21% | 124.44% | 3.85% |
| Average Basic Shares Outstanding | -5.22% | -2.78% | -5.37% | -8.17% | -8.73% |
| Average Diluted Shares Outstanding | -7.17% | -2.66% | -4.88% | -6.03% | -7.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |